VanEck Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.6M | Sell |
79,865
-3,218
| -4% | -$890K | 0.01% | 471 |
|
|
2026
Q1 | $24.5M | Buy |
83,083
+2,018
| +2% | +$599K | 0.02% | 399 |
|
|
2025
Q4 | $22.1M | Buy |
81,065
+64,519
| +390% | +$17.5M | 0.02% | 370 |
|
|
2025
Q3 | $4.47M | Buy |
16,546
+784
| +5% | +$213K | ﹤0.01% | 797 |
|
|
2025
Q2 | $4.34M | Sell |
15,762
-27,242
| -63% | -$7.41M | ﹤0.01% | 777 |
|
|
2025
Q1 | $11.4M | Sell |
43,004
-4,799
| -10% | -$1.18M | 0.01% | 441 |
|
|
2024
Q4 | $11.1M | Sell |
47,803
-24,705
| -34% | -$5.68M | 0.01% | 438 |
|
|
2024
Q3 | $16.5M | Sell |
72,508
-181
| -0.2% | -$37.5K | 0.02% | 350 |
|
|
2024
Q2 | $14.3M | Sell |
72,689
-7,258
| -9% | -$1.5M | 0.02% | 342 |
|
|
2024
Q1 | $17.2M | Sell |
79,947
-4,398
| -5% | -$924K | 0.03% | 302 |
|
|
2023
Q4 | $17.8M | Sell |
84,345
-12,176
| -13% | -$2.6M | 0.03% | 274 |
|
|
2023
Q3 | $19.3M | Sell |
96,521
-3,009
| -3% | -$598K | 0.04% | 246 |
|
|
2023
Q2 | $18.4M | Buy |
99,530
+6,559
| +7% | +$1.21M | 0.04% | 258 |
|
|
2023
Q1 | $17.8M | Buy |
92,971
+16,501
| +22% | +$2.98M | 0.04% | 257 |
|
|
2022
Q4 | $12.9M | Buy |
76,470
+32,348
| +73% | +$5.62M | 0.03% | 301 |
|
|
2022
Q3 | $7.82M | Buy |
44,122
+1,821
| +4% | +$360K | 0.02% | 355 |
|
|
2022
Q2 | $8.66M | Buy |
42,301
+935
| +2% | +$198K | 0.02% | 355 |
|
|
2022
Q1 | $9.84M | Sell |
41,366
-3,179
| -7% | -$747K | 0.02% | 365 |
|
|
2021
Q4 | $10.2M | Buy |
44,545
+32,169
| +260% | +$7.08M | 0.02% | 372 |
|
|
2021
Q3 | $2.39M | Buy |
12,376
+2,593
| +27% | +$525K | 0.01% | 630 |
|
|
2021
Q2 | $2.08M | Sell |
9,783
-573
| -6% | -$121K | ﹤0.01% | 659 |
|
|
2021
Q1 | $2.12M | Buy |
10,356
+2,792
| +37% | +$550K | 0.01% | 599 |
|
|
2020
Q4 | $1.38M | Sell |
7,564
-177
| -2% | -$30.1K | ﹤0.01% | 609 |
|
|
2020
Q3 | $1.29M | Sell |
7,741
-9,789
| -56% | -$1.65M | ﹤0.01% | 579 |
|
|
2020
Q2 | $2.85M | Sell |
17,530
-5,386
| -24% | -$965K | 0.01% | 430 |
|
|
2020
Q1 | $3.96M | Sell |
22,916
-9,682
| -30% | -$1.93M | 0.02% | 358 |
|
|
2019
Q4 | $6.54M | Buy |
32,598
+1,385
| +4% | +$284K | 0.03% | 325 |
|
|
2019
Q3 | $6.6M | Buy |
31,213
+1,001
| +3% | +$209K | 0.03% | 286 |
|
|
2019
Q2 | $5.86M | Buy |
30,212
+2,797
| +10% | +$516K | 0.03% | 295 |
|
|
2019
Q1 | $4.51M | Buy |
27,415
+23,224
| +554% | +$4.11M | 0.02% | 346 |
|
|
2018
Q4 | $788K | Buy |
4,191
+143
| +4% | +$26.4K | ﹤0.01% | 574 |
|
|
2018
Q3 | $689K | Sell |
4,048
-54
| -1% | -$9.09K | ﹤0.01% | 638 |
|
|
2018
Q2 | $672K | Buy |
+4,102
| New | +$670K | ﹤0.01% | 630 |
|
Other funds holding CME
VanEck Associates's CME Position: Q2 2026 in Review
VanEck Associates reduced its CME Group (CME) stake by 3.9% in Q2 2026, selling an estimated $890K and leaving 79,865 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #471.
VanEck Associates first reported a position in CME in Q2 2018 and has held it in 33 quarters since. The position peaked at $24.5M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- VanEck Associates held 79,865 shares of CME Group worth $17.6M as of Q2 2026.
- VanEck Associates sold 3,218 CME Group shares in Q2 2026, an estimated $890K.
- CME Group made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #471 holding.
- VanEck Associates first reported a position in CME Group in Q2 2018 and has held it in 33 quarters since.
- VanEck Associates's CME Group position peaked at $24.5M in Q1 2026.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.